Physician profile
Robert A Campbell
NPI 1992936710
$10,318.29
in general payments reported to CMS, 2019-2025
7 companies · $858 in 2025
The $858 reported for 2025 was more than what 86% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,458 · 2020: $2,644 · 2021: $297 · 2022: $866 · 2023: $1,812 · 2024: $2,383 · 2025: $858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,990 · Travel and Lodging: $992 · Education: $70.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,990.43 |
| Travel and Lodging | $992.17 |
| Education | $70.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,117.00 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Vercise |
| Si-Bone, INC. | $51.83 | 2025 | |
| Abbvie INC. | $42.64 | 2023 | Botox, Ubrelvy |
| Merz North America, INC. | $36.52 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.05 | 2022 | |
| Bioventus LLC | $24.11 | 2020-2021 | |
| Saluda Medical Americas, INC. | $19.14 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.